Comparative abilities of adiposity markers to predict two or more metabolic syndrome components.

<p>Comparative abilities of adiposity markers to predict two or more metabolic syndrome components.</p

HIV-related characteristics, and median anthropometric and biochemical parameters in the study sample.

<p>HIV-related characteristics, and median anthropometric and biochemical parameters in the study sample.</p

Performance measures of different waist circumference cut-offs to predict two or more metabolic syndrome components in men and women.

<p>Performance measures of different waist circumference cut-offs to predict two or more metabolic syndrome components in men and women.</p

Comparison of the MS prevalence using the JIS waist circumference thresholds, and the derived cutoffs in this and other African populations.

<p>Comparison of the MS prevalence using the JIS waist circumference thresholds, and the derived cutoffs in this and other African populations.</p

Optimal waist circumference threshold for diagnosing metabolic syndrome in African people living with HIV infection - Fig 2

<p><b>Receiver operating characteristic (ROC) curve of the waist circumference in detecting the presence of two or more metabolic syndrome components in HIV-infected African men (A) and women (B).</b> The ROC curves show the optimal cutoff of 82.9 cm in men (sensitivity: 59%, specificity: 74%) corresponding to a c-statistic of 0.659 (A), and the optimal cutoff of 92.0 cm in women (sensitivity: 63.5%, specificity: 64.2%) corresponding to a c-statistic of 0.649 (B).</p

Standard of Reporting for Diagnostic Accuracy Studies (STARD) diagram to report flow of participants through the study.

<p>WC, waist circumference; MA, metabolic abnormalities, ≥2 non-adipose components: BP≥130/85mmHg, triglycerides≥1.7mmol/L, high density lipoprotein cholesterol<1.03mmol/l in men and <1.3mmol/l in women, fasting glucose≥5.6mmol/l; ^a WC cutoffs recommended by the JIS criteria; ^bWC cutoffs derived in the present study.</p

Additional file 1: of Polypharmacy among HIV positive older adults on anti-retroviral therapy attending an urban clinic in Uganda

Medication side-effects questionnaire used in study where the participant was asked to indicate any symptoms s/he has which s/he believes is a side-effect of the medication s/he is taking. Medication side-effects questionnaire. (DOCX 18 kb

Additional file 1: Figure S1. of Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme

Capability, opportunity, and motivation ratings of community members, non-physician health workers and doctors in 15 research projects at initial and subsequent assessment

Additional file 14: of Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme

PER 11 Assessment. Launching a Salt Substitute to Reduce Blood Pressure at the Population Level (PER 11)

Additional file 13: of Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme

FJI/WSM 10 Assessment. Cost Effectiveness of Salt Reduction Interventions in Pacific Islands (FJI/WSM 10)